DanielB.MarkMDMPH
Cardiology • Durham, NCCardiac Critical Care
Professor of Medicine, Duke University School of Medicine
Dr. Mark is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2301 Erwin Rd
Durham, NC 27705Phone+1 919-681-9660- Is this information wrong?
Summary
- Dr. Daniel Mark is a cardiologist in Durham, NC and is affiliated with Duke University Hospital. He received his medical degree from Tufts University School of Medicine and has been in practice 39 years. He specializes in cardiac critical care and is experienced in general cardiology.
Education & Training
Duke University HospitalFellowship, Cardiovascular Disease, 1982 - 1985
University of Virginia Medical CenterResidency, Internal Medicine, 1979 - 1982
Tufts University School of MedicineClass of 1978
Certifications & Licensure
MA State Medical License 1981 - 2025
NC State Medical License 1982 - 2024
FL State Medical License 2014 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1998
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease Start of enrollment: 2002 Jan 01
- Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Start of enrollment: 2009 Nov 13
- Trial to Assess Chelation Therapy 2 Start of enrollment: 2016 Oct 01
Publications & Presentations
PubMed
- Prognostic Impact of Sinus Rhythm in Atrial Fibrillation Patients: Separating Rhythm Outcomes From Randomized Strategy Findings From the CABANA Trial.T Jared Bunch, Adam P Silverstein, Kerry L Lee, Hussein R Al-Khalidi, Gerhard Hindricks, Alexander Romanov, Evgeny Pokushalov, Melanie Daniels, , Jeanne E Poole, Trist...> ;Circulation. Arrhythmia and Electrophysiology. 2024 Apr 17
- Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2).Ana Navas-Acien, Regina M Santella, Bonnie R Joubert, Zhen Huang, Yuliya Lokhnygina, Francisco Ujueta, Irina Gurvich, Nancy J LoIacono, Filippo Ravalli, Cynthia D Ward...> ;American Heart Journal. 2024 Apr 13
- Regional differences in outcomes with ablation versus drug therapy for atrial fibrillation: Results from the CABANA trial.Riccardo Cappato, Daniel B Mark, Adam P Silverstein, Peter A Noseworthy, Gianluca Bonitta, Jeanne E Poole, Jonathan P Piccini, Tristram D Bahnson, Melanie R Daniels, H...> ;American Heart Journal. 2024 Apr 1
- Join now to see all
Journal Articles
- Original Investigation Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart FailureLawton S Cooper, Ileana L Pina, David J Whellan, Daniel B Mark, Kirkwood F Adams, ScienceDirect
- New Research Paper Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy with Validated Patient-Centric Risk EstimatesJeanne E Poole, Todd F Dardas, Gust H Bardy, Ramin Shadman, Wayne C Levy, Daniel B Mark, ScienceDirect
Lectures
- Quality of Life and Cost-Effectiveness Associated with the Late Opening of a Total Occluded ArteryAmerican Heart Association, Scientific Sessions 2007, Orlando, Florida, USA
- Quality of Life and Cost-Effectiveness Associated with the Late Opening of a Total Occluded ArteryScientific Sessions 2007, Orlando, Florida, USA
Press Mentions
Clinical Practice Guideline: Full Text 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesDecember 17th, 2020
Medicine Today: A Look a Treatment of Atrial FibrillationApril 29th, 2019- Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients with Atrial Fibrillation: The CABANA Randomized Clinical TrialApril 2nd, 2019
- Join now to see all
Grant Support
- The Ischemia Trial - EqolNational Heart, Lung, And Blood Institute2011–2012
- Cabana Eqol TrialNational Heart, Lung, And Blood Institute2009–2012
- Postdoctoral Training In Cardiovascular Clinical ResearchNational Heart, Lung, And Blood Institute2004–2011
- Promise Trial: Eqol Coordinating CenterNational Heart, Lung, And Blood Institute2009–2010
- Stich Trial- Economics &Quality Of Life Core LaboratoryNational Heart, Lung, And Blood Institute2002–2008
- Postdoctoral Training In Cardiovascular Clinical Resear*National Heart, Lung, And Blood Institute2003
- Economics And Quality Of Life In The Occluded Artery TRINational Heart, Lung, And Blood Institute1999–2003
- Economics And Quality Of Life In SCD HeftNational Heart, Lung, And Blood Institute1997–2003
- Mediators Of Social Support In Coronary DiseaseNational Heart, Lung, And Blood Institute1992–1996
- Multidimensional Technology Assessment Of PTCAAgency For Healthcare Research And Quality1987–1991
Professional Memberships
- Member
Hospital Affiliations
Duke University HospitalDurham, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
